Cell survival pathways targeted in rare lung disease affecting women

Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.

Detalles Bibliográficos
Autores principales: Yang, Bennett, Moss, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Focus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171799/
https://www.ncbi.nlm.nih.gov/pubmed/37163598
http://dx.doi.org/10.1126/sciadv.adi1215
_version_ 1785039500070617088
author Yang, Bennett
Moss, Joel
author_facet Yang, Bennett
Moss, Joel
author_sort Yang, Bennett
collection PubMed
description Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.
format Online
Article
Text
id pubmed-10171799
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-101717992023-05-11 Cell survival pathways targeted in rare lung disease affecting women Yang, Bennett Moss, Joel Sci Adv Focus Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival. American Association for the Advancement of Science 2023-05-10 /pmc/articles/PMC10171799/ /pubmed/37163598 http://dx.doi.org/10.1126/sciadv.adi1215 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Focus
Yang, Bennett
Moss, Joel
Cell survival pathways targeted in rare lung disease affecting women
title Cell survival pathways targeted in rare lung disease affecting women
title_full Cell survival pathways targeted in rare lung disease affecting women
title_fullStr Cell survival pathways targeted in rare lung disease affecting women
title_full_unstemmed Cell survival pathways targeted in rare lung disease affecting women
title_short Cell survival pathways targeted in rare lung disease affecting women
title_sort cell survival pathways targeted in rare lung disease affecting women
topic Focus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171799/
https://www.ncbi.nlm.nih.gov/pubmed/37163598
http://dx.doi.org/10.1126/sciadv.adi1215
work_keys_str_mv AT yangbennett cellsurvivalpathwaystargetedinrarelungdiseaseaffectingwomen
AT mossjoel cellsurvivalpathwaystargetedinrarelungdiseaseaffectingwomen

Ejemplares similares